| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Total research and development | 7,772,109 | - |
| Total general and administrative | 6,579,735 | - |
| Operating loss | -14,351,844 | - |
| Issuance cost and change in fair value of derivative | 1,016,682 | - |
| Interest and other income (expense), net | -808,475 | - |
| Loss before income taxes | -16,177,001 | - |
| Net loss and comprehensive loss | -16,177,001 | -8,591,426 |
| Depreciation | 419,062 | 312,280 |
| Stock-based compensation | 1,137,863 | 545,039 |
| Accretion of discount on note payable | 222,113 | 15,353 |
| Amortization of debt issue costs | 21,831 | 155,135 |
| Loss on debt extinguishment | -451,834 | - |
| Issuance cost and change in fair value of derivative | 1,016,682 | - |
| Other receivables | -7,284 | -6,740 |
| Prepaid expenses and other current assets | 872,402 | 879,743 |
| Operating lease right-of-use assets | 1,295,033 | 1,348,209 |
| Trade accounts payable and accrued expenses | 156,492 | -935,266 |
| Current portion of operating lease liability | 100,461 | 92,971 |
| Long-term portion of operating lease liability | 1,162,921 | 1,223,587 |
| Net cash used in operating activities | -13,647,893 | -9,403,539 |
| Purchase of property and equipment | 5,925 | 5,925 |
| Net cash used in investing activities | -5,925 | -5,925 |
| Proceeds from the issuance of common stock and pre-funded common stock purchase warrants, net of fees | 7,565,637 | 6,102,756 |
| Principal payments on finance lease obligations | 4,430 | 4,430 |
| Net cash provided by financing activities | 7,561,207 | 6,098,326 |
| Net increase (decrease) in cash and cash equivalents | -6,092,611 | -3,311,138 |
| Cash and cash equivalents at beginning of period | 12,211,321 | - |
| Cash and cash equivalents at end of period | 6,118,710 | - |
Cingulate Inc. (CING)
Cingulate Inc. (CING)